Binbin Cheng
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- Ginseng Biological Effects and Applications
- RNA Interference and Gene Delivery
- Viral Infectious Diseases and Gene Expression in Insects
- Phytochemical Studies and Bioactivities
- Natural product bioactivities and synthesis
- CRISPR and Genetic Engineering
Papers in
-
- RNA Interference and Gene Delivery 4
- Extracellular vesicles in disease 4
- Ginseng Biological Effects and Applications 4
- RNA modifications and cancer 4
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Changquan Ling (23 shared papers)Juan Du (16 shared papers)Shufang Liang (11 shared papers)Wanfu Lin (11 shared papers)Xiaoyan Zhu (1 shared paper)Shu Li (9 shared papers)Wentao Jia (6 shared papers)Yani Zhang (7 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (5 papers)Frontiers in Pharmacology (2 papers)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2 papers)Oncology Reports (2 papers)Molecular Cancer (1 paper)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Binbin Cheng
53 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 154
- Molecular Biology 662
- Pharmacology 80
- Genetics 210
- Complementary and alternative medicine 56
Countries citing papers authored by Binbin Cheng
This map shows the geographic impact of Binbin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Cheng more than expected).
Fields of papers citing papers by Binbin Cheng
This network shows the impact of papers produced by Binbin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Cheng. The network helps show where Binbin Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Binbin Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 103 | |
| 2 | 2010 | 86 | |
| 3 | 2012 | 79 | |
| 4 | 2012 | 63 | |
| 5 | 2014 | 60 | |
| 6 | 2017 | 55 | |
| 7 | 2011 | 51 | |
| 8 | 2023 | 48 | |
| 9 | 2022 | 47 | |
| 10 | 2018 | 39 | |
| 11 | 2014 | 38 | |
| 12 | 2014 | 37 | |
| 13 | 2016 | 33 | |
| 14 | 2018 | 32 | |
| 15 | 2019 | 32 | |
| 16 | 2015 | 32 | |
| 17 | 2019 | 29 | |
| 18 | 2011 | 28 | |
| 19 | 2021 | 26 | |
| 20 | 2018 | 25 |
About Binbin Cheng
Binbin Cheng is a scholar working on Molecular Biology, Cancer Research, Genetics, Epidemiology and Immunology, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (5 papers), MicroRNA in disease regulation (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer-related molecular mechanisms research (4 papers), Extracellular vesicles in disease (4 papers), Ginseng Biological Effects and Applications (4 papers), RNA modifications and cancer (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (154 citations), Molecular Biology (662 citations), Pharmacology (80 citations), Genetics (210 citations) and Complementary and alternative medicine (56 citations). Binbin Cheng has collaborated with scholars based in China, United States and India. Frequent co-authors include Changquan Ling, Juan Du, Shufang Liang, Wanfu Lin, Xiaoyan Zhu, Shu Li, Wentao Jia, Yani Zhang, Arun Srivastava and Li Weng. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Frontiers in Pharmacology, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Oncology Reports and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.